EUVIMEDEUVIMED entdecken
Mixed-Methods-StudieOpen Access · CC BY-NC 4.0

Glycogen storage disease type III: a mixed-methods study to assess the burden of disease

Ayla Evins, Jill Mayhew, Tricia Cimms, Julie Whyte iD, Kathy Vong, Elizabeth Hribal, Christopher J Evans, Andrew Grimm

Therapeutic Advances in Endocrinology and Metabolism · 2024-05 · 15

DOI: 10.1177/20420188231224233 ↗

Kurz gefasst

Mixed-Methods-Studie in der Zeitschrift Therapeutic Advances in Endocrinology and Metabolism, online erschienen am 08.01.2024. Verfasst von Ayla Evins und 7 weiteren Autor:innen. Beteiligte Einrichtung: Ultragenyx Pharmaceutical Inc., 60 Leveroni Court, Novato, CA, 94949 USA. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Glycogen storage disease type III (GSD III) is a rare inherited disorder that results from a glycogen debranching enzyme deficiency.

Objectives

The purpose of this research was to collect data on the signs, symptoms, and impacts of GSD III from the perspective of adult patients and caregivers of individuals with GSD III.

Design

Online survey and qualitative interviews.

Methods

Following institutional review board approval, adult patients and caregivers of children with GSD III were recruited through advocacy networks and clinical sites. If eligible, participants were consented, screened, and sent a survey and/or participated in a 60-min interview. The survey and interview included questions about family history, diagnosis, signs and symptoms, impacts, and management of GSD III. Conceptual models were developed following the analysis of results.

Results

In all, 29 adults and 46 caregivers completed the online survey and/or the interviews with 73 survey and 19 interview respondents. Adults and caregivers reported digestive, musculoskeletal, growth and physical appearance, and cardiac signs and symptoms. Liver conditions were reported by most respondents (83%). Adults and caregivers frequently reported impacts such as difficulty keeping up with peers (77%) and difficulty exercising/difficulty with physical activity (53%). Hypoglycemia was frequently reported in both adults and children, with more than half reporting hospitalizations due to hypoglycemia. Caregivers focused on hypoglycemia when reporting signs/symptoms that most interfere with their child’s life and prevention of hypoglycemia as a desired outcome for an effective therapy. Adults most often reported muscle weakness as a top interfering symptom and the most important goal of a potential therapy. Impacts were also reported in activities of daily living, cognitive, emotional, work/school, and sleep domains.

Conclusion

Individuals with GSD III experience a broad spectrum of symptoms and disease impacts. There is an unmet need for therapies that improve metabolic control, reduce the burden of dietary management, reduce fatigue and liver problems, and improve muscle strength and function.

Schlagwörter

Stichwörter der Autor:innen

conceptual modelglycogen storage disease type IIImixed methodsqualitative researchrare disease

Autor:innen und Institutionen

  • Ultragenyx Pharmaceutical Inc., 60 Leveroni Court, Novato, CA, 94949 USA.
  • Ultragenyx Pharmaceutical Inc., Novato, CA, USA.
  • Endpoint Outcomes, A Lumanity Company, Boston, MA and Long Beach, CA, USA.

ORCID-Profile: Julie Whyte

Zitieren

APA

Evins, A., Mayhew, J., Cimms, T., Whyte, J., Vong, K., Hribal, E., Evans, C. J., & Grimm, A. (2024). Glycogen storage disease type III: a mixed-methods study to assess the burden of disease. Therapeutic Advances in Endocrinology and Metabolism, 15. https://doi.org/10.1177/20420188231224233

Vancouver

Evins A, Mayhew J, Cimms T, Whyte J, Vong K, Hribal E, et al. Glycogen storage disease type III: a mixed-methods study to assess the burden of disease. Therapeutic Advances in Endocrinology and Metabolism. 2024;15. doi:10.1177/20420188231224233

BibTeX
@article{Evins2024,
  author = {Evins, Ayla and Mayhew, Jill and Cimms, Tricia and Whyte, Julie and Vong, Kathy and Hribal, Elizabeth and Evans, Christopher J and Grimm, Andrew},
  title = {Glycogen storage disease type III: a mixed-methods study to assess the burden of disease},
  journal = {Therapeutic Advances in Endocrinology and Metabolism},
  year = {2024},
  volume = {15},
  doi = {10.1177/20420188231224233}
}
Kostenlos starten →